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Abstract
Background: Genotype networks are representations of genetic variation data that are complementary to
phylogenetic trees. A genotype network is a graph whose nodes are genotypes (DNA sequences) with the same
broadly defined phenotype. Two nodes are connected if they differ in some minimal way, e.g., in a single nucleotide.
Results: We analyze human genome variation data from the 1,000 genomes project, and construct haploid genotype
(haplotype) networks for 12,235 protein coding genes. The structure of these networks varies widely among genes,
indicating different patterns of variation despite a shared evolutionary history. We focus on those genes whose
genotype networks show many cycles, which can indicate homoplasy, i.e., parallel or convergent evolution, on
the sequence level.
Conclusion: For 42 genes, the observed number of cycles is so large that it cannot be explained by either chance
homoplasy or recombination. When analyzing possible explanations, we discovered evidence for positive selection
in 21 of these genes and, in addition, a potential role for constrained variation and purifying selection. Balancing
selection plays at most a small role. The 42 genes with excess cycles are enriched in functions related to immunity
and response to pathogens. Genotype networks are representations of genetic variation data that can help understand
unusual patterns of genomic variation.
Keywords: Genotype networks, Genetic variation, Natural selection, Human genome
Background
The patterns and causes of genotypic variation in human
genes have been a focus of great recent interest in evo-
lutionary biology. Different processes such as natural
selection, genetic recombination, genetic drift, demog-
raphy, as well as physicochemical properties of cells,
can influence this diversity. Various methods have been
devised to represent and quantify genetic variation and
to detect its causes [1–10].
Here we use a novel approach based on genotype
networks to represent and analyze genetic variation in
human genes. Genotype networks are graphs that con-
sist of nodes, which correspond to genotypes with the
same phenotype, where sameness can be defined as
narrowly as enzyme activity, or as broadly as viability.
Nodes that differ in some minimal way from each other
are adjacent, i.e., connected by an edge in such a graph.
The genotypes we consider are haploid genotypes (hap-
lotypes) of human genes in a sample of the human
population, and we call two genotypes adjacent if they
differ in a single nucleotide. Genotype networks can be
useful to address various evolutionary questions, such
as how novel adaptations originate, and what role
phenotypic robustness or plasticity play in adaptation
[11]. In the past, they have been mostly built from
computational models of genotype-phenotype maps
[12–15], but high-throughput genotyping allows us to
build genotype networks from experimental data [16].
Representing such data in the form of a network makes
the large analytical toolbox of graph theory available,
which has been useful in fields as different as ecology
and the social sciences [17–20].
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A common form of representation for genetic variation
data is the phylogenetic tree, which shows the evolution-
ary relationship among a set of taxa, individuals, or genes
that constitute the leaves of the tree. The common ances-
tors of these taxa form the interior nodes of such a tree.
In a gene tree, these ancestors can be reconstructed with
the help of probabilistic models of sequence evolution
[21–23]. Phylogenetic trees are by definition acyclic
graphs: They do not contain cycles – paths of edges that
start from a node, pass through other nodes, and return
to the same node.
The acyclic nature of phylogenetic trees implies one
major limitation of such trees: They cannot easily
accommodate evolutionary genealogies more complex
than simple vertical descent with modification [24–27].
Such genealogies can lead to reticulate networks of
phylogenetic relationships. Thus, multiple mechanisms
to create genetic diversity, such as hybridization, allo-
polyploidization, sexual reproduction, recombination,
gene conversion, and homoplasy, which lead to mosaic
patterns of relationships among nodes are not easily
accommodated in tree-like structures. Genotype net-
works provide information complementary to phylo-
genetic trees that are not subject to this limitation,
because they can accommodate cycles.
Figure 1 shows a short cycle in a hypothetical genotype
network involving four DNA sequences. Edges reflect
adjacent genotypes that differ in a single nucleotide.
Assume, for example, that genotype 1 is ancestral to
the other genotypes, and different substitutions (A10T
and A20G) produce genotypes 2 and 3 from it. Geno-
type 3 then experiences an additional A10T substitution
that creates genotype 4. This mutational path leads to a
closed cycle, where three of the four edges reflect a
substitution event. The fourth edge is a consequence of
the first three events, because they render genotype 2
adjacent to genotype 4. Similar scenarios can be devel-
oped if a genotype different from genotype 1 is ances-
tral. Regardless of this ancestor, cycles require sequence
changes that render the descendants of one (or more)
genotypes more similar rather than less similar. In
other words, cycles require some form of homoplasy,
i.e., parallel or convergent evolution [28–32]. More
generally, homoplasy is said to exist when two lineages
display the same genetic or phenotypic characters, even
though this similarity has not arisen through common
ancestry [28, 32].
Homoplastic sequence evolution has been documented
in a wide variety of molecules [33–39]. It can be caused
by chance alone, which is expected to be rare in long
evolving biopolymers with multiple kinds of monomers,
because random mutations are more likely to cause such
polymers to diverge than to converge. Mutational biases,
strong selective constraints on sequence evolution [37],
Fig. 1 A hypothetical example of a four-node cycle in a haplotype network. The example indicates a hypothetical DNA sequence where two
nucleotide changes occur at position 10 and 20. Circles (nodes) correspond to genotypes. An edge connects two nodes if they differ by a single
mutation. Lettering next to each node indicates the nucleotides at which two genotypes differ. Edge labels show changes required to create a
genotype from its neighbor, e.g., “A20G” indicates a change from A to G at position 20 of the hypothetical sequence. In the example, mutations
at positions 10 and 20 create genotypes 2 and 3 from genotype 1 . Then, either genotype 2 mutates at position 20 from A to G, or genotype 3
mutates at position 10 from A to T, or both of these mutations take place, and create genotype 4
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positive selection [33–37], or genetic recombination [40]
can also cause homoplasy.
Here we construct haploid genotype networks for each
of 12,235 genes in the human genome, based on single
nucleotide variation data available for 1,092 individuals
from four continents [10]. We analyze short cycles up to
length eight in these networks, and find that the haploid
genotype (haplotype) networks of 42 genes show a sig-
nificant excess of cycles that cannot be explained by
chance alone. After having excluded recombination as a
prominent cause of these cycles, we focus on positive se-
lection as a possible cause, and present evidence that in
at least some of these genes positive selection may help
explain the existence of cycles.
Results
Constructing and characterizing haplotype networks
To construct genotype networks for 1,092 human indivi-
duals, we used haploid genotypes (haplotypes) with single
nucleotide variation data available from the 1,000 ge-
nomes project [10]. Thus, our genotype networks are
haplotype networks, and from now on, we use the term
haplotype network instead of genotype network. For each
human gene, we constructed one haplotype network. Two
principal definitions of such a network are germane for
this paper. By the first definition, a haplotype network of a
human gene is a graph whose nodes correspond to
protein-coding DNA sequences of the gene in different
individuals. Two nodes (sequences) are adjacent if they
differ in a single base pair (i.e., by either a synonymous or
non-synonymous change). By the second definition, two
nodes are adjacent if their coding sequences differ by a
single non-synonymous (amino acid replacement) change.
The second kind of network can thus also be viewed as a
network of proteins or amino acid sequences, in which
neighboring proteins differ in a single amino acid.
We first created both DNA- and protein-based haplo-
type networks based on the above definition, collapsing
those nodes with identical sequences into one (see
Methods). Networks can be made of one or more com-
ponents. Each component is a subgraph in which any
two nodes are connected to each other by a path of
edges. We found that the average size of the largest
connected component – commonly referred to as the
giant component – relative to total network size is signifi-
cantly larger in protein-based networks (12,235 proteins, a
fraction 0.975 of the total network) than in DNA networks
(15,841 DNA sequences, 0.940 of the total network)
(Mann–Whitney U test – p-value = 7.01e-156) (See also
Fig. 2c). Because our statistical analyses focus on the
giant component of each haplotype network and work
best if this component comprises as many nodes as
possible, we focus on protein-based haplotype networks
for the rest of this contribution. The 1,000 genomes
dataset we use contains information from 19,744 genes,
but we constructed haplotype networks only for those
12,235 protein-coding sequences that showed at least
one amino acid variant.
Figure 2a and b illustrate with two examples that
haplotype networks for different genes can differ greatly
in their topology. The left network (Fig. 2a), derived
from the gene OTOG, which encodes Otogelin, com-
prises 181 nodes organized into a single component,
whereas the right network, from gene HLA-B (Major
histocompatibility complex, class I, B) is highly fragmen-
ted and has 1,545 nodes in 1,111 different components
(See Additional file 1: Figure S1 for a different represen-
tation of the two networks.)
More generally, Fig. 2c shows the distributions of the
number of components and the size of the largest com-
ponent for all genes we considered. There are 11,155
networks with only a single component, but most of these
networks are small, with an average of 5.52 sequences.
The network with the most components is the highly frag-
mented HLA-B network with 1,111 components. HLA-B
is known to be under strong balancing [41] and divergent
selection [42], which causes great genotypic diversity. This
diversity translates into high network fragmentation, i.e., a
network with many components. Some haplotype net-
works have very large giant components with up to 552
sequences. However, in most (10,587) networks, the lar-
gest component is very small, comprising a maximum
of ten sequences. The network with the largest giant
component where all sequences fall into that compo-
nent is that of OTOG (Fig. 2a).
Cycles in haplotype networks
A cycle in a network is a series of edges starting from
one node and ending with the same node, while passing
other nodes along the cycle only once. In haplotype net-
works constructed from biallelic gene variants, the sim-
plest elementary cycle, i.e. a cycle not decomposable into
smaller cycles, is a square. The reason is that cycles with
an odd number of edges, e.g. triangles or pentagons, are
impossible when all SNPs are biallelic. Figure 1 shows a
square that involves the mutation of a hypothetical DNA
sequence at two different sites (positions 10 and 20).
Next to each circle (sequence) the nucleotide residues at
these positions are indicated, and along the edges, the
specific nucleotide changes that occurred. If genotype 1
is the most recent common ancestor of its neighbors,
then its two neighbors have undergone two different
mutations: Specifically, genotype 2 has experienced a
change from A to T at position 10 and genotype 3 has a
change from A to G at position 20. To form the single
genotype 4 from its ancestors, i.e. from either genotype
2 or 3, either genotype 2 has undergone a change from
A to G at position 20, or genotype 3 has undergone a
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change from A to T at position 10, so that the descen-
dants of the two ancestral sequences 2 and 3 become
not only more similar but identical to one another. It is
not necessary for both of sequences 2 and 3 to mutate
to form genotype 4, but a mutation in either of them
can lead to the genotype and form a cycle. Regardless of
whether genotype 1 or any other genotype is the com-
mon ancestor of the others, a square like this requires
convergent sequence change.
In long biopolymer sequences with multiple mono-
mers that evolve through random mutation alone, cycles
should be rare, because it is unlikely that mutations be-
come reversed to create sequences more similar to one
another. However cycles can be introduced by mutation
biases that allow only certain residues to change, or by
selection that causes only certain changes to survive, i.e.,
by evolutionary constraints. Another possibility is re-
combination, which might occur between genotypes 2
and 3, which can result in genotype 4. The same mecha-
nisms can give rise to longer cycles (e.g., length 6 or 8,
Additional file 2: Figure S2).
Figure 3a shows the distribution of the number of
squares in all networks. 7,373 of 12,235 networks had no
squares. The network with the most squares is that of
the gene DNAH11 and contains 1,043 squares. The inset
of Fig. 3a shows the distribution of hexagons and octa-
gons. The networks with the largest number of hexagons
(74) and octagons (4) are those of genes MAP2K3 and
HLA-B, respectively. Note the small numbers of hexagons
and octagons compared to squares. Even though we enu-
merated elementary cycles up to length eight – beyond
that, our analyses become computationally too costly –
we focus most of the following analysis on squares, be-
cause they are by far the most abundant cycles.
Unconstrained or constrained mutation cannot explain
the large number of cycles in many networks
Because some amount of homoplasy can occur by chance
alone, we wished to determine whether all squares we ob-
served could have occurred by chance homoplasy. To this
end, we created randomized haplotype networks in which
the same amount of evolutionary change occurred as in
the actual networks.
In our first randomization procedure, we created a
(simulated) DNA sequence of the same length as the
coding sequence of a gene, and created a haplotype
network from it by simulating a pattern of mutations
designed to yield a network with the same number of
Fig. 2 Haplotype networks vary greatly in structure among genes. a Haplotype network of the gene OTOG (Otogelin). Among all protein-based
haplotype networks comprising more than 100 sequences, OTOG has the network with the largest giant component where all nodes fall into this
component (181 nodes and a single component). b Haplotype network of the gene HLA-B, which is the most fragmented network, with 1,545
nodes in 1,111 components. Circles in a) and b) correspond to different genotypes, while edges connect genotypes that differ by a single
point mutation. Circle color and size correspond to the degree (number of neighbors) of the node, where darker and larger nodes have a
higher degree. c Number of components versus network size for DNA-based (blue circles) and protein-based haplotype networks (red circles).
Circle size in c) corresponds to the relative size of the giant component within each haplotype network
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edges (number of nonsynonymous changes) and the same
distribution of degrees (number of neighbors) as the
actual network (see Methods). Specifically, we compared
the number of squares in each haplotype network to 1,000
such randomly generated networks, and found 4,267
genes whose actual number of cycles was greater than all
of the 1,000 randomly generated networks. Thus, based
on this criterion there are 4,267 genes whose total number
of squares cannot be explained by chance homoplasy
alone (p-value ≈ 0.001 – FDR ([43]) at 0.05) (a full list of
these genes can be found in Additional file 3).
One can argue that this procedure does not take into
consideration the actual patterns of variation observed in
the data, namely that only a small subsets of sites in any
one gene have been subject to mutation, and that all of
the sites are biallelic, that is, only two variant nucleotides
occur in them. Both patterns arise from the fact that the
human population sample is not highly diverged, and that
natural selection constrained the evolution of these se-
quences, i.e., it eliminated some mutations that occurred
in them. We thus modified our randomization procedure
to reflect these facts (see Methods). With these more con-
servative criteria, we still found 42 genes (0.34 % of all
genes analyzed) whose haplotype networks have signifi-
cantly more squares in their networks than expected by
chance alone (Table 1). That is, their number of squares
cannot be explained by mutational patterns and purifying
selection alone. Figure 3b shows, as an example, the num-
ber of squares (21, orange arrow) in the haplotype network
of HLA-B, which is 6.52 standard deviations greater than
the mean number of cycles (5.36) in 1,000 randomized
networks (black histogram). Figure 3c shows the number
of squares in all 42 networks (black circles), together with
the mean (blue circles), minimum, and maximum (blue
shaded regions) number of squares for 1,000 randomized
networks created for each of the 42 haplotype networks.
Fig. 3 Distribution of the number of cycles in all networks and in networks with an excess of squares. a Distribution of the number of elementary
squares, as well as elementary hexagons and octagons (inset) in all protein-based networks. b Distribution of the number of squares in 1,000
randomized networks derived from the giant component of the HLA-B network, whose number of squares (21) is indicated by a red arrow.
c Number of squares (black circles) in the largest components of the haplotype networks of 42 genes with significantly more squares than expected
by chance alone, together with the mean number of squares (blue circles) found in 1,000 randomly generated networks for each gene. Shaded areas
depict the maximum and minimum number of squares in the randomized networks. Note the logarithmic scale on the vertical axis.
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Additional file 4: Figure S3 shows the distribution of
elementary cycles with length four, six and eight among
the 42 genes with an excess of squares, and Fig. 4 shows
the proportion of the sequences that form part of a
square in the largest connected component of each
gene network. For some genes, such as POTED (POTE
ankyrin domain family, member D) all sequences form
part of a square, and even for genes where the propor-
tion of sequences in a square is low, such as HLA-C
(major histocompatibility complex, class I, C) and TTN
(titin), it exceeds 40 % (Fig. 4).
We note that the 42 networks with an excess of
squares are otherwise very heterogeneous in their prop-
erties. They range from the network of MKI67 (marker
of proliferation Ki-67) where only 23 nodes lie in the lar-
gest connected component, to the network of DNAH11
(dynein, axonemal, heavy chain 11), where 538 nodes do
(see Additional file 5: Figure S4 for the distribution of
component sizes). Some of the networks have very few
components, such as that of POTED with a single compo-
nent, whereas others have many components, such as the
highly fragmented HLA-B network with 1,111 compo-
nents (see Additional file 6: Figure S5 for the distribution
of component numbers). Even properties within the
largest connected components are heterogeneous. For
example, in some networks, such as that of PKD1L1,
the distribution of the numbers of neighbors of each se-
quence is highly right-skewed and dominated by se-
quences with few neighbors, while in others it is more
symmetric (PRAMEF2, Additional file 7). Assortativity co-
efficients, which quantify the tendency of each node to
connect to other nodes with a similar number of neigh-
bors, also vary broadly. Some networks are assortative
(sequences with many neighbors are adjacent to other
sequences with many neighbors), whereas others are
disassortative (Additional file 8: Figure S7).
Gene Ontology (GO) enrichment analysis on biological
processes shows several immune system-related pro-
cesses that are enriched in the 42 genes, namely “antigen
processing and presentation of endogenous peptide anti-
gens” and “interferon-gamma-mediated signaling path-
way” (see Additional file 3 for full results of the analysis
and parameters). GO enrichment analysis of molecular
functions reveals the two enriched functions “calcium
ion binding” and “peptide antigen binding”. “Peptide
antigen binding” is again associated with the immune
system.
Given the strong representation of HLA genes among
genes with an excess of cycles, we also asked how the
GO enrichment analysis would change if we excluded
the HLA genes. We found a single enriched biological
process, namely “O-glycan processing”, and two enriched
molecular functions, namely “calcium ion binding” and
“extracellular matrix constituent, lubricant activity”.
Table 1 Genes with an excess of squares in their giant component
Gene name Previous evidence
of positive selection
Number of squares
in the giant component
TTN None 11
MKI67 None 14
OBSCN None 15
PKD1L2 None 18
MUC16 None 22
MUC17 None 26
IGFN1 [54] 31
GPR98 [54] 31
PRUNE2 None 35
SYNE2 None 41
AHNAK2 None 41
HLA-DPB1 [62, 78–81] 48
ALPK2 None 50
HLA-C [62, 78–81] 50
FLG None 54
PRAMEF2 [54] 55
HRNR None 55
MUC5B None 58
PCLO [54] 67
HLA-A [62, 78–81] 67
MUC12 None 71
LAMA5 [54] 76
CYP2A7 [82] 76
HLA-B [62, 78–81] 76
POTED None 80
NEB None 96
MUC4 None 121
PKD1L1 None 160
FBN3 [54] 197
DCHS2 None 205
FRAS1 [54] 269
PLIN4 None 298
EYS None 316
FCGBP [54] 350
TG None 365
USH2A [54] 475
LILRB3 None 475
LILRA6 None 482
DNAH17 [54] 494
HLA-DRB1 [55, 62, 78–81] 507
DNAH5 [54] 602
DNAH11 None 1043
The number of squares in these genes cannot be explained by random
homoplasy or mutational constraints. The middle column cites studies that
provide evidence for positive selection, wherever such evidence is available.
After FDR correction, the p-value of the statistical test comparing the actual
number of cycles against that in 1,000 randomized networks (with random
mutations and mutational constraints) is 0.087 for all genes
R. Vahdati and Wagner BMC Evolutionary Biology  (2016) 16:154 Page 6 of 19
We also asked whether genes with an excess of
squares preferentially occurred in specific KEGG [44] or
Reactome [45] pathways. Six genes were preferentially
associated with KEGG pathways. They include TG
(thyroglobulin) and the genes in the HLA family. The
enriched pathways comprise “Epstein-Barr virus infec-
tion”, “Autoimmune thyroid disease”, “HTLV-I infection”,
“Viral myocarditis”, “Allograft rejection”, “Phagosome”,
“Antigen processing and presentation”, “Graft-versus-host
disease”, “Cell adhesion molecules (CAMs)”, “Herpes sim-
plex infection”, and “Type I diabetes mellitus”.
For Reactome pathways, we found twelve genes
enriched in six pathways. The genes include those en-
coding Mucins, the HLA family and LILR family genes
(MUC4, MUC5B, MUC12, MUC16, MUC17, HLA-A,
HLA-B, HLA-C, HLA-DRB1, HLADPB1, LILRA6, and
LILRB3). The enriched pathways are “Termination of O-
glycan biosynthesis”, “Interferon gamma signaling”,
“Endosomal/Vacuolar pathway”, “Immunoregulatory in-
teractions between a Lymphoid and a non-Lymphoid
cell”, “Antigen Presentation: Folding, assembly and pep-
tide loading of class I MHC” and “Defective GALNT12
causes colorectal cancer 1 (CRCS1)”. We note that both
enriched KEGG and Reactome pathways include several
immunity-related pathways.
Recombination cannot account for an excess of squares
in most networks
To exclude the possibility that genetic recombination
may account for the excess of squares in some networks,
we performed two complementary analyses. First, we
simulated for each gene the effect of recombination on
haplotype network structure by creating haplotype net-
works based on a set of sequences that were subject to
approximately as many recombination events as oc-
curred in the human population since their common
ancestry, as well as to as many mutations as there are
edges in the network (see Methods). We repeated this
process 1,000 times for each gene, creating 1,000 simu-
lated haplotype networks, and counted the number of
squares in them. For each of the 42 genes, the empirical
network showed more squares than each of the 1,000
simulated networks (Additional file 9: Figure S8).
Fig. 4 Proportion of sequences that are part of a cycle. Proportion (horizontal axis) and actual number of sequences (right vertical axis) that are
part of a square in the giant connected components of haplotype networks for those 42 genes (left horizontal axis) with a significant excess
of squares
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In the second analysis, we asked whether gene conver-
sion, a process of unidirectional recombination in which
only one of the recombining sequences changes, may have
caused the excess of squares [46, 47]. To this end, we used
the program GENECONV (version 1.81a) [48] to detect
gene conversion among the sequences in the giant com-
ponents of the 42 haplotype networks. We used sequences
comprising both synonymous and non-synonymous
changes to give the program more power in finding gene
conversion events. Only one gene showed any sign of gene
conversion, and it did so for only two of 114 sequences in
CYP2A7 (cytochrome P450, family 2, subfamily A, poly-
peptide 7). In sum, based on these analyses, it seems
unlikely that recombination can explain the excess of
squares we observe in the haplotype networks of 42 genes.
Positive selection as a potential cause of squares
Positive selection can be a driver for homoplastic or
convergent evolution, where two separate lineages evolve
the same trait independently [49]. Because such adaptive
homoplasy can occur not only at the phenotypic level
[50, 51], but also at the sequence level [34, 35, 52], we
wished to find out whether positive selection can help
explain the excess of squares we observed in the haplo-
type networks of 42 genes.
Previous studies had indeed indicated positive selec-
tion for at least 17 of the 42 genes (Hughes and Nei
1988, 1989; Ohta 1991; Hughes and Yeager 1998; Birtle
et al. 2005; Crespi and Summers 2006; Proux et al. 2009;
Kawashima et al. 2012) (Table 1). In addition, we used
results from a branch-site likelihood test [53] which
indicates positive selection based on a ratio dN / dS > 1
observed along one or more branches of a phylogenetic
tree. This test has been applied to vertebrate genes in
the Selectome database [54], which indicates that 12 of
our 42 genes with abundant squares show patterns of
positive selection, either in primates or in the bony ver-
tebrates (Euteleostomi, Table 1 and Additional file 10:
Table S2). This number – 12 of 42 – is unlikely to be
observed by chance alone (p = 0.0004; hypergeometric
test, based on 2,125 unique genes in the human genome
under positive selection according to Selectome (data
provided by the authors of Selectome)). In addition, we
used the XP-CLR (cross-population composite likelihood
ratio) test for neutrality [55] (see Methods). The test
compares different populations to identify rapid changes
in a locus’ allele frequency that cannot be explained by
random drift alone. In applying this test, we used a test
statistics [56] pre-computed over 2 kb sliding windows
that covered the human genome, and asked for each of
our 42 genes whose haplotype network showed an
excess of squares, whether two or more of the windows
where the test-statistic indicated the action of positive
section (p = 0.01) overlapped with the gene (see Methods).
By this criterion, six of our 42 genes showed evidence of
positive selection in at least one population (Additional
file 11: Table S1 and Additional file 12: Table S3). Overall,
21 of our 42 genes with an excess of squares showed signs
of positive selection by at least one of these criteria or
by previous work.
We also analyzed patterns of synonymous and non-
synonymous changes in more detail. A commonly used
indicator of positive selection for two protein-coding
DNA sequences is dN / dS, i.e. the ratio of nonsynon-
ymous changes dN per nonsynonymous site to synonym-
ous changes dS per synonymous site. Values of dN / dS > 1
can indicate positive selection [57, 58]. Unfortunately,
dN / dS can be computed only for sequences more dis-
tantly related than those in our haplotype networks. The
reason is that in these networks, adjacent sequence pairs
differ only in a single nonsynonymous mutation, and
many adjacent pairs do not even show a single synonym-
ous change. More specifically, in the giant component of
our networks, up to 80 % of sequence pairs do not show
a single synonymous mutation (Additional file 13: Figure
S9), and this incidence of synonymous mutations is simi-
larly low in the entire network. Moreover, it has been
suggested that for very closely related sequences, dN / dS
is not a sensitive indicator of positive selection [59]. For
these reasons, we compared the incidence of nonsynon-
ymous and synonymous changes among groups of edges
(see Methods), reasoning that groups of edges with very
few synonymous changes might provide hints that some
or all members of the group may have been subject to
positive selection. Most edges show no synonymous
changes at all in some networks, which hints that posi-
tive selection may have played a role in creating their
pattern of diversity (Additional file 13: Figure S9).
We specifically compared edges with no synonymous
change inside squares and outside squares. While the
fractions of edges without synonymous changes inside
squares was not significantly different from those out-
side squares (Fisher’s exact test on 2 × 2 contingency ta-
bles, Additional file 14: Figure S10), the average number
of synonymous changes on edges inside squares was sig-
nificantly smaller than that outside squares for 14 % (6)
of the genes (Mann-Whitney U test, p-value = 0.05, FDR
corrected). Figure 5 shows the average number of syn-
onymous changes per edge for edges inside squares di-
vided by that for edges outside squares. For genes where
this ratio is below 1 (red vertical line) the average number
of synonymous changes are smaller inside squares than
outside squares. Overall, the distribution of synonymous
changes among edges inside squares and outside squares
does not suggest that all incidences of excessive squares
are due to positive selection, but it suggests that positive
selection may have contributed to this excess for at least
some genes.
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Using a test based on the hypergeometric distribution
[60], we found no significant overlap between the genes
that showed evidence of positive selection in the XP-
CLR test and those genes among our 42 focal genes that
(i) have significantly fewer synonymous mutations inside
the squares than outside the squares of their haplotype
network (2 common genes) or (ii) had been identified in
several previous studies as being subject to positive
selection (3 common genes).
Balancing selection is not a likely cause of an excess of
squares
In a final analysis, we also asked for evidence of balan-
cing selection, which manifests itself as an elevated
amount of heterozygosity and can in principle produce
squares. Consider, for example, the square in Fig. 6, in
which nodes represent hypothetical diploid genotypes.
Next to each circle (genotype) the nucleotide residues at
positions 10 and 20 are indicated, and along the edges,
the specific nucleotide changes that occurred for the first
of two haplotypes. If genotype 1 is the most recent com-
mon ancestor of genotypes 2 and 3, then a substitution
at site 20 in the first haplotype of genotype 1 creates
genotype 2, and a substitution at site 10 of the first
haplotype creates genotype 3. If balancing selection is
acting on both sites (10 and 20), individuals 2 and 3 will
be favored over individual 1, because they are heterozy-
gous at one of the two sites under balancing selection. A
further substitution to genotype 4, would create a
double-heterozygous genotype – and a square – that is
even more favored by balancing selection.
We computed for each gene the fraction of heterozy-
gous individuals averaged over all sites that experienced
nonsynonymous changes in at least one individual of the
Fig. 5 Ratio of the average number of synonymous changes per edge for edges inside squares relative to edges outside squares. The red line
corresponds to a value of this ratio that is equal to one, i.e, edges inside and outside squares have the same average number of synonymous changes.
Bars that end to the left (right) of this line indicate genes in which the average number of synonymous changes per edge is lower (higher) inside
squares than outside squares. *, **, and *** indicate that the difference between the average number of synonymous changes inside versus
outside squares is significant at p-values of 0.05, 0.01, and 0.001, respectively (Mann-Whitney U test). The p-values are corrected following [43]
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sample population (see Methods). Among our 42 genes
with an excess of squares, we found no significant
(Pearson’s r, p-value = 0.512) correlation between the
number of squares and heterozygosity. For all 19,744
genes, we found a very small (Pearson’s r = 0.066) yet
significant correlation (p = 3.42 × 10-13) between het-
erozygosity and the number of squares in a gene’s
haplotype network (Additional file 15: Figure S11). In
sum, balancing selection is not a likely explanation for
the prevalence of squares in some genes.
Multiple genes whose haplotype networks show an
excess of squares are implicated in immune functions
Especially prominent among the 42 genes whose haplo-
type networks show an excess of squares are genes with
immune functions. Such genes are also known to be
subject to frequent positive selection [61]. For example,
five of the 42 genes belong to the human leukocyte anti-
gen (HLA) family. These are the genes HLA-A, HLA-B,
HLA-C, HLA-DPB1, and HLA-DRB1. HLA genes show
the highest level of polymorphisms in the human gen-
ome [2, 62], and display multiple signatures of positive
selection, including a high dN / dS in antigen-recognition
sites, trans-species polymorphisms, high levels of hetero-
zygosity, as well as long range haplotypes, a key signa-
ture of recent positive selection [62].
Five more among the 42 genes with an excess of
squares encode mucins, which are important for the im-
mune response, because they help form mucus that can
prevent pathogen entry, and cooperate with antibodies
to fight pathogens [63–65]. These are MUC4, MUC5B,
MUC12, MUC16 and MUC17.
Two more among the 42 genes, LILRB3 and LILRA6,
encode leukocyte immunoglobulin-like receptors, which
cooperate with MHC proteins. LILRB1, another member
of this family, has co-evolved with HLA, which is under
positive selection in sub-Saharan population [66].
Another immune-relevant gene among the 42 genes
is FCGBP, which may play an important role in im-
mune protection and inflammation in the intestines
of primates [67].
Discussion
We show that the haplotype networks of 42 genes display
a significant excess of squares that cannot be explained by
chance homoplasy, genetic recombination, or balancing
selection alone. This leaves constrained evolution as a
prominent candidate cause, which limits the diversity
of alleles that are generated or preserved in a sequence.
While such constrained evolution can have multiple
causes [68], strong purifying and positive selection are
most relevant for the kind of data we analyze.
Fig. 6 Balancing selection can produce cycles. The example indicates a hypothetical diploid genotype where two nucleotide changes occur at
position 10 and 20. Circles (nodes) correspond to genotypes. An edge connects two nodes if they differ by a single mutation. Lettering next to
each node indicates the nucleotides at which two genotypes differ. Edge labels show changes required to create a genotype from its neighbor,
e.g., “A20G” indicates a change from A to G at position 20 of the first haplotype of the hypothetical genotype. See text for details
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Strong purifying selection may play a role in the oc-
currence of squares, because we observed significantly
fewer squares for many genes in our randomization tests
when we allowed the whole protein coding sequence to
change, and when we permitted substitutions to any nu-
cleotide. In addition, some of the genes with an excess
of squares may have experienced positive selection. First,
up to 80 % of edges in the giant component of some of
these genes do not have any synonymous mutations at
all (Additional file 13: Figure S9). Second, six of the
genes with an excess of squares (14 %) have significantly
more synonymous changes outside their squares than
inside them (Fig. 5). Third, six genes contained at least
two adjacent windows with a significantly high value of
the XP-CLR test statistic that can indicate positive se-
lection (Additional file 11: Table S1). Fourth, previous
studies have suggested that 17 of the 42 genes with an
excess of squares have been subject to positive selection
(Table 1). Finally, multiple genes among those with an
excess of squares are involved in immune functions,
which are frequently subject to positive selection [61].
More generally, it is relevant that there is a mounting
number of known genes where convergence at the se-
quence level has been caused by positive selection. For
example, sequence convergence occurred in the peptide-
binding regions of human and mouse class Ib genes in
the major histocompatibility complex (MHC), the same
gene family in which five members show an excess of
squares in our study [39]. The motor protein Prestin
which is involved in the mammalian auditory system has
experienced adaptive sequence convergence between
echolocating bats and echolocating dolphins [33]. Two
other genes involved in the mammalian auditory system,
Tmc1 and Pjvk, also have experienced convergence due
to positive selection [37]. In addition, whole genome se-
quencing of four bat species showed extensive genome-
wide convergence among these taxa [34]. Moreover,
extensive convergent evolution occurred between snake
and agamid lizard mitochondrial genomes, much of
which may be adaptive [35].
Our analysis is based on some 1,000 human genomes,
which raises the question how its results might be af-
fected as the size of the available data set increases. Most
importantly, a larger data set would lead to larger and
more connected networks. Our analysis is focused on
the largest connected component of each network, and
increasing the size of the largest connected component
could lead to more cycles just by chance alone. Indeed,
larger connected components of a haplotype network in
our data set also contain more cycles (Additional file 16:
Figure S12). This pattern also extends to those networks
with a significant excess of cycles. Specifically, giant
component sizes are significantly larger for networks
that have a significant excess of cycles than for the
remainder of the haplotype networks (Additional file 17:
Figure S13). Conversely, a higher fraction of genes with
an excess of cycles have large giant components (>100
nodes). These observations suggest that increasing the
size of our data set might not just increase the overall
number of cycles, but also the number of haplotype net-
works with an excess of cycles. In other words, it would
increase the sensitivity of our analysis.
A recent study [69] has shown that HLA genes show
reference allele bias in the 1,000 genomes data. Removing
these alleles from the dataset could in principle lead to
smaller giant components in the HLA networks and
hence to fewer cycles. However, this is unlikely to materi-
ally affect our observations, because the largest compo-
nents, with one exception, comprise a small fraction of
the HLA networks (0.05, 0.26, 0.09, 0.60 and 0.04 for
HLA-B, HLA-DPB1, HLA-A, HLA-DRB1 and HLA-C,
respectively). Thus, most removed alleles would fall
into other components, and their removal would thus
not affect our giant-component-based analysis.
In sum, while we have not been able to explain the
abundance of squares conclusively, we suggest that a
mix of constrained evolution through purifying selection
and positive selection may be responsible. As data from
more and more individuals from the global human
population become available, it will be possible to disen-
tangle these causes. Such data may also help explain the
great differences in haplotype network structure among
the human genes we characterized here.
Conclusions
We explored a novel way of representing human genetic
variation data through a network-based approach whose
strengths are complementary to phylogenetic trees.
Despite the fact that the genes in the genomes we
analyze have a shared phylogenetic history, they show
very diverse properties in their haplotype networks.
Specifically, these networks show different numbers of
genotypes (Fig. 2c), different extents of fragmentation
(Additional file 6: Figure S5), different degree distribu-
tions (Additional file 7: Figure S6), and different assor-
tativity (Additional file 8: Figure S7). Our analysis
focuses on the feature of these networks that cannot
be easily represented in phylogenetic trees, i.e., cycles.
Phylogenetic trees are acyclic, and thus not ideally
suited to represent evolutionary histories more com-
plex than direct descent, such as allopolyploidization,
convergent evolution, sexual reproduction, recombin-
ation and horizontal gene transfer. Such events can
transform a tree-like evolutionary history into a reticu-
late network. Haplotype networks can represent such
reticulation, and can thus complement phylogenetic
trees in their ability to represent and describe evolu-
tionary processes.
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Methods
Construction of haplotype networks
We focused our analysis on haplotype networks built
from amino acid changing (non-synonymous) mutations
of all genes in the human genome, and supplemented
this analysis with data on synonymous mutations. The
data we use consists of SNPs called from sequencing of
1,092 individuals by the 1,000 genomes project phase I
[10]. First we downloaded variant call format (VCF) files
[70] containing all genotypic variants for all 1,092 indi-
viduals, as well as the functional annotation of the vari-
ants (build 23.11.2010) provided by the 1,000 genomes
project. At this stage we had 22 VCF files, one for each
of the 22 autosomal chromosomes.
Next, using the software VCFtools [70], we filtered the
VCF files by removing all sites with a “FILTER” tag other
than “PASS”, as well as indels, non-phased variants, and
all variants with a minor allele frequency smaller than
0.01. Analyzing VCF files after filtering, we found no
SNP with more than two alleles, which is why all our
analyses are based on biallelic SNPs. Subsequently, we
used the previously obtained functional annotation
information to create three VCF files for each gene,
which contained nonsynonymous, synonymous, and
both synonymous and non-synonymous SNPs in the
gene’s protein coding region.
The networks we analyze are built on the basis of haplo-
types, i.e., we considered for each individual its two hap-
loid genotypes separately. Each network is a graph whose
nodes are haplotypes, and two haplotypes are connected
by edges if they differ in a single SNP. Overall, we
analyzed 2,184 haplotypes, and established a separate
haplotype network for each of 17,744 human genes. We
constructed and analyzed all networks with the help of the
iGraph package for Python (version 0.6.5) [71], and visual-
ized them using Gephi (version 0.8.2-beta) [72].
For our analysis of protein-based haplotype networks,
we merged two haploid genotypes into a single node of
the network if they had identical haplotypes based on their
non-synonymous SNPs. Some of our analyses required us
to compute the number of synonymous changes between
adjacent nodes of these networks, and because a node
does not necessarily correspond to a unique haplotype,
this number is also not unique – different haplotypes en-
code the same protein but they may differ at synonymous
sites. Wherever this was the case, we used in our analysis
the average number of synonymous changes along an
edge, computed by enumerating synonymous changes
between all possible pairs of haplotypes for the incident
nodes.
Analysis of cycles and other network properties
Cycles in a haplotype network are paths that start and
end at the same node, while visiting every other node in
the path exactly once. We note that in a haplotype net-
work of biallelic SNPs, no cycles of uneven length are
possible. We first focused on cycles of length four, i.e.,
squares, and calculated their number through exhaustive
enumeration. Specifically, we started from any one node
and walked from there to all its neighbors, the neigh-
bor’s neighbors, and so on, avoiding previously visited
nodes, until we had visited five nodes. Any sequence of
five nodes is a square if the first and last nodes in the
sequence are identical. Repeating the same procedure
from all nodes in the network allowed us to enumerate
all squares (not double-counting squares that we had
found more than once). We applied the same approach
to find longer cycles of length six and eight. We call
such a longer cycle elementary, if it is not decompo-
sable into shorter cycles, and we verified this property
for each longer cycle.
Randomized haplotype networks
To ask whether the number of cycles in an empirically
observed haplotype network is greater than expected
by chance alone, we created randomized haplotype net-
works for each gene. More specifically, this analysis
focused on the largest component of each gene’s haplo-
type network, which comprises on average 97.5 % of a
network’s nodes.
A randomized network may have fewer or more cycles
than the actual network. Consider the hypothetical
square uvyw in a haplotype network, where v and w are
located at two diagonally opposed corners of the square.
In creating a random network, we might start from a
node (sequence) u, mutate the sequence twice at ran-
dom to create nodes w and v, and then mutate w and v
once more (into w’ and v’), so that we have created a
random network of four edges. If w’ and v’ are not iden-
tical to each other and to the sequence y in the square
this random network is not cyclic, whereas the actual
four-node network is. (The opposite is also possible,
where the randomization process creates a cycle where
the actual network does not contain one.)
We performed two types of randomization analyses,
one only with mutation and the other with mutation
and recombination. Before we explain these analyses, we
highlight a methodological detail. As we mentioned in
the introduction of the paper, three substitutions are ne-
cessary to observe a square (and four are possible). In
our randomization analyses described below, we always
use four mutations, which is a statistically conservative
choice. It allows edges in randomized networks that have
no corresponding edge in the data-based networks, and
some of these edges can lead to the creation of add-
itional cycles. Thus, the number of cycles expected by
chance alone (i.e., in randomized networks) will be
somewhat higher with our procedure than in a population
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evolving subject to the assumptions we make below.
This renders any assertion that a haplotype network
contains more cycles than expected by chance statisti-
cally conservative.
Randomization with mutation
In a first randomization analysis, we aimed to create, for
each gene, networks with the same number of nucleo-
tide changes as the gene’s actual network. To construct
such a random network, we began with a single random
sequence that we then mutated iteratively. Specifically,
we chose a random node u from the actual network and
assigned a random sequence to it. Then we mutated the
sequence as many times as u had neighbors in the actual
network, and assigned each mutated sequence to one of
the neighbors. Next, we cycled over each of these neigh-
bors, and for each such neighbor v we mutated its
assigned sequence as many times as the number of
neighbors v had in the actual network. We repeated this
simulated mutation process until all nodes in the ori-
ginal network had been visited, and for as many muta-
tions as there were edges in the original network, thus
creating a random network based on the same number
of edges as the original network. Overall, for each gene
we created 1,000 such random networks, and counted
the squares in all of them.
In this process, we used two different kinds of starting
sequences. The first was a random DNA sequence with
the same length as the full length protein coding DNA
sequence, where each of the four nucleotides was equally
likely to occur at every site. Because most human genes
have multiple transcripts and the transcripts may overlap
with each other, we considered the total length of a
gene’s protein coding DNA as the stretch of DNA that
was covered by at least one transcript. We allowed every
site to mutate into one of the three other nucleotides, as
long as the mutation was nonsynonymous. To create
nonsynonymous mutations, we chose a transcript for the
gene at random, and mutated a random nucleotide site
within that transcript. We mutated this nucleotide to
some other randomly chosen nucleotide, and determined
whether the change was nonsynonymous. If so, we kept
the mutation, otherwise we repeated this procedure until
we had found a nonsynonyomus change.
The second kind of starting sequence takes into ac-
count the observed pattern of variation in the sequences
under consideration. This sequence comprised only as
many nucleotide monomers as there were sites with
nonsynonymous changes in a gene’s protein coding
amino acid sequence. Moreover, since our data com-
prises only biallelic SNPs, we allowed each site in this se-
quence to convert only between two types of residues.
We note that relaxing either assumption would lead to
even fewer squares in a randomized network than we
found. Thus, a randomization test based on this starting
sequence is highly conservative.
Since more than 1,000 randomization tests for each
network were not computationally feasible, the p-values
of our tests could not be smaller than 0.001. To correct
for multiple testing, we first assigned a p-value of 0.001
to those networks that had more squares than each of
their corresponding 1,000 randomized networks. Then
we adjusted p-values of all the networks that had at
least one square (4,862 networks) using the procedure
of Benjamini and Hochberg [43]. When building net-
works from full-length protein coding sequences, and
from shorter sequences that reflect only the number of
polymorphic sites, the adjusted p-values of genes whose
randomized networks never had as many or more squares
than the actual network were p = 0.001 and p = 0.087,
respectively.
Randomization with recombination
To assess whether recombination can help explain the
number of squares in human haplotype networks, we
constructed, for each gene, 1,000 randomly generated
networks that incorporate recombination during their
construction, and determined the distribution of squares
in these networks. To build a random network with re-
combination, we started with a collection or “population”
of diploid sequences, whose size was half of the number of
sequences in the giant component of the focal gene’s
haplotype network. (We chose this size because we con-
ceive of these sequence pairs as diploid “individuals” from
which we would later construct a random haplotype net-
work.) All individuals started with the same homozygous
randomly generated sequence pair, which was as long as
the number of nonsynonymous polymorphic sites in the
gene. For each such sequence pair, we determined a num-
ber of mutation and recombination events that they were
to undergo, as described further below. We then mutated
each individual and recombined the two copies of its
genome as many times as specified by these numbers.
Subsequently, we randomly paired individuals and cre-
ated each of two “offspring” from each pair by randomly
sampling (with replacement) a haplotype from each par-
ent in the pair to an offspring. We used these offspring
to construct the random haplotype network, connecting
two haplotypes if they differed by a single nonsynon-
ymous mutation.
In this procedure, we wanted to generate a total num-
ber of mutations (for all sequences in the population)
that was equal to the number of edges (nonsynonymous
changes) in the giant component of the focal haplotype
network. To this end, we first determined the average
number of mutations per individual M as the total
number of desired mutations divided by the number of
haplotypes in the population. If M was an integer, we
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mutated each individual exactly M times. If M was a
decimal number and M <1, then we introduced a single
mutation into the individual with probability M, and no
mutation with probability 1-M. If M was a decimal
number and M >1, then M lay in the interval (k,k + 1),
where k is some integer. In this case, we introduced k + 1
mutations into the individual with probability M-k, and k
mutations with probability 1-(M-k). We introduced each
mutation into each haplotype by choosing a random site
from the sequence and changing its nucleotide. To keep
the variational constraints imposed by biallelic variation at
each site, we only allowed each nucleotide to mutate to
one other nucleotide.
If two sequences were to be recombined in the simula-
tion, then recombination took place after mutation, and
occurred between haplotypes of each sequence pair. To
recombine a sequence v with a sequence w, we chose a
random position in the sequence, and then replaced all
the sites after that position in sequence v with residues
in sequence w, and also replaced all sites after that pos-
ition in sequence w with residues in sequence v. If two
sequences were to be recombined more than once (see
below), we repeated this process.
We next describe how we determined the number of
recombination events for each haplotype network, where
we aimed at introducing as many recombination events
as are likely to have taken place in a gene, based on
available polymorphism data. We calculated the fraction
r of sequence pairs to be recombined once for each gene
and used it for all random networks to be created for
that gene. To obtain r, we first multiplied the average
per-generation recombination rate in the human genome
(0.952 cM/Mb per generation, calculated based on data
from [73]) with the number of generations since the se-
quences in our data set may have shared a common an-
cestor. To estimate this number of generations, we used
the number of synonymous mutations observed in each
gene in our data set. Specifically, we used the following
relationship
generations to common ancestry
¼ S
L  μ  Ne ð1Þ
where S in the numerator designates the observed num-
ber of synonymous sites for that gene (determined using
the filtered VCF files from the 1,000 genomes data). In
the denominator, L is the length of the gene, including
introns, as retrieved from Biomart (version 0.7, [74]),
μ is the average human mutation rate per nucleotide
(1.1 × 10-8) [75], and Ne is the effective population
size, for which we used a value of Ne = 10,000 [76].
After having computed the estimated number of recom-
bination events for each gene, we divided this number by
the sample size of our data (1,092) to obtain the number
of recombination events r per sequence pair. If r was an
integer, then each sequence pair would undergo exactly r
crossing over events. If r was a decimal number and r <1,
then we introduced a single crossing over event into the
pair with probability r, and no such event with probability
1-r. If r was a decimal number and r > 1, then r lay in the
interval (k,k + 1), where k is some integer. In this case, we
introduced k + 1 crossing over events with probability r-k,
and k crossing over events with probability 1-(r-k). Over-
all, our recombination procedure ensures that the number
of recombination events is approximately the same as
expected for a set of sequences with comparable diver-
sity as that observed in our data.
In addition to the parameters described above, we con-
structed randomized network with higher recombination
rates, to account for heterogeneous recombination rates
across the genome, or higher effective population size,
to account for higher effective population size for some
genes such as HLA genes. Specifically, we constructed
randomized networks with a ten-fold higher effective
population size, i.e. 100,000 individuals, and randomized
networks with twice the recombination rate that we had
used initially. The new recombination rate is 1.90 cM/
Mb.
The changes in recombination rate and effective popu-
lation size did not change the final results. All the genes
that were tested had more cycles in the giant component
of their networks than any of the 1,000 randomized net-
works. Additional file 18: Figure S14 shows the mean
and range of cycle count in the new randomized net-
works compared with the cycle count in original net-
works of the genes.
If many synonymous mutations are shared among
sequences, the procedure from Eq. 1 would overestimate
the number of needed recombination events if we simply
counted the number S of synonymous changes across
edges of a haplotype network. To find out whether this
could be the case, we computed the number of synonym-
ous changes that are shared among edges. (We note that
each node in a haplotype network can correspond to mul-
tiple sequences that encode the same amino acid sequence,
but may differ in synonymous changes, such that each edge
can have multiple sets of associated synonymous changes.)
To this end, we counted the fraction of synonymous
changes on each edge that are also present in some other
edge of the network. This fraction is small, with a median
of 0.0459 and a mean of 0.0613. Thus, shared ancestry of
synonymous changes is unlikely to confound our estima-
tion of the number of recombination events.
XP-CLR neutrality test
We chose to use the XP-CLR (cross-population composite
likelihood ratio) test [55] to test for neutral sequence
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evolution, because this test is robust to demographic
history and recombination rate heterogeneity, and it de-
tects both recent and ancient selective sweeps [55].
Briefly, the test searches for regions in the genome in
which allele frequencies have changed too quickly to be
explained by genetic drift. We used test statistics calcu-
lated for 2 kbp sliding windows calculated by [56] for
the whole genome, based on the 1,000 genomes data
[10]. Specifically, we performed this test for three popula-
tions, namely the CEU population (Utah Residents with
Northern and Western European ancestry), the CHB
population (Han Chinese in Beijing, China) and the YRI
population (Yoruba in Ibadan, Nigeria) [75], which
amounts to six possible population pairs and thus six cal-
culations of the test statistics. To find the significance of
the test statistics for any one gene of interest, we rank-
ordered all the 2 kb windows in the genome by p-value,
omitting windows with a value of the statistic equal to
zero, i.e., lacking information. To identify candidate genes
subject to positive selection, we determined which win-
dows overlapped with each one of the 19,221 human
genes. Only about 3 % of the windows that overlapped
genes had a value of the statistic that indicated positive se-
lection (at p = 0.05), but these windows overlapped with
nearly 20 % of genes. This suggests that using this criter-
ion to identify genes subject to positive selection would
lead to a high false-discovery rate of positively selected
genes. Therefore, we chose a more conservative criterion
of calling only those genes subject to positive selection
where at least two contiguous windows showed a signifi-
cantly high test statistic (p = 0.01). According to this cri-
terion, only 2 % of genes were subject to positive selection
in each of the six population pairs.
Calculating heterozygosity
To calculate the heterozygosity of any one gene, we used
not haplotypes but (diploid) genotypes, and calculated
the fraction of heterozygote individuals in our data set at
each site where a non-synonymous amino acid change
had occurred. We used the average of this value over all
sites as our measure of the gene’s heterozygosity.
Gene enrichment analysis
We used the g: Profiler web tool (Version: r1622_e84_eg31)
[77] to ask if any gene ontology (GO) categories of bio-
logical processes and molecular functions or any path-
ways are significantly enriched in the 42 genes with a
significant excess of squares in their haplotype network.
In this analysis, we used default parameters of the tool,
with two exceptions. First, we only searched for enrich-
ment among GO biological processes and molecular
functions, as well as among KEGG and Reactome path-
ways. Second, we set the hierarchical filtering of results,
which provides a compact data representation, to “best
per parent (moderate)”. GO terms are hierarchically re-
lated, and not filtering them hierarchically leads to un-
manageably long and indiscriminate lists of enriched
functions. The filtering uses the parent-wise grouping of
significant terms and results in shorter GO output that
is easier to analyze. Details of test results and parameters
can be found in the electronic supplementary material.
Gene conversion analysis
We used the GENECONV software on Linux (version
1.81a) [48] to detect gene conversion (with default pa-
rameters). The sequences that we supplied to the pro-
gram included the haplotypes that comprised the giant
component of the gene and included both synonymous
and nonsynonymous changes.
Additional files
Additional file 1: Figure S1. Illustration of two haplotype networks,
one highly connected and the other highly fragmented. a) Haplotype
network of gene OTOG (Otogelin). Among all protein-based haplotype
networks comprising more than 100 sequences, OTOG has the network
with the largest giant component where all nodes fall into this component
(181 nodes and a single component). b) Haplotype network of gene HLA-B,
which is the most fragmented network, with 1,545 nodes in 1,111
components. Circles in a) and b) correspond to different genotypes,
while edges connect genotypes that differ by a single point mutation.
Circle color corresponds to the degree (number of neighbors) of the
node, where darker nodes have a higher degree, and circle size corresponds
to the number of haploid individuals with that genotype, where larger
nodes are shared among more haploid individuals (PDF 3358 kb)
Additional file 2: Figure S2. Cycles in haplotype networks illustrated
with the example of a hexagon and an octagon. Circles (nodes) correspond
to genotypes. An edge connects two nodes if they differ by a single
mutation. Lettering next to each node indicates the nucleotides at
which two genotypes differ. Edge labels show changes required to
create a genotype from its neighbor, e.g., “A20G” indicates a change
from A to G at position 20 of the hypothetical sequence. a) hypothetical
hexagon in which six nucleotide changes occur, two each at positions 10,
20 and 30. If one starts from genotype 1, this genotype mutates twice and
produces genotypes 2 and 3. Those genotypes in turn mutate to produce
genotypes 4 and 5. Then either genotype 4 mutates at position 30 from A
to T, or genotype 5 mutates at position 10 from A to G, or both of these
mutations happen together, to produce genotype 6. This can be happen
when there are evolutionary constraints that restrict other mutations.
Recombination can also be responsible for this pattern. This pattern will
be the same if one starts from any other node. b) hypothetical octagon in
which eight nucleotide changes occur, two each at positions 10, 20, 30, and
40. Same pattern that was explained for a) can be explained here, with the
only difference that there are more positions that are mutating. (PDF 193 kb)
Additional file 3: This ZIP file contains the following documents.
1. genes_with_excess_of_cycles_exonLength_nucleotideMutations.txt:
List of genes with excess of cycles when randomized networks are
constructed from entire gene coding sequences (all four nucleotide
mutations allowed). 2. gprofiler_results_100fragmentedGenes_largerthan
10.xlsx: Gene ontology enrichment analysis results for the 100 most
fragmented genes with a network comprising more than 10 sequences.
3. gprofiler_results_GO_function_process.xlsx: Gene ontology enrichment
analysis of molecular functions and biological processes for the 42 genes
with an excess of cycles. 4. gprofiler_results_GO_function_process_
NoHLAGenes.xlsx: Gene ontology enrichment analysis of molecular
functions and biological processes for the 42 genes with an excess of
cycles, excluding the HLA genes. 5. gprofiler_results_KEGG.xlsx: KEGG
pathways enrichment analysis for the 42 genes with an excess of cycles.
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6. gprofiler_results_reactome.xlsx: Reactome pathways enrichment
analysis for the 42 genes with an excess of cycles. 7. list_of_most_
fragmented_networks.txt: List of 100 most fragmented networks among
all haplotype networks comprising more than 10 nodes. Fragmentation is
computed as the number of components divided by the size of the
network (higher values correspond to greater fragmentation). (ZIP 63 kb)
Additional file 4: Figure S3. Frequency of squares, hexagons and
octagons among the 42 genes with an excess of cycles. The plot shows
the frequency of elementary cycles of length 4, 6 and 8 in the giant
component of genes with an excess of squares in their haplotype
network. Note that the apparent discrepancy to Fig. 3a comes from
the fact that Fig. 3a shows cycle numbers for haplotype networks of
all genes. (PDF 296 kb)
Additional file 5: Figure S4. Distribution of the size of the largest
component in haplotype networks of 42 genes with an excess of squares
in the largest component. The smallest giant component occurs in the
network of MKI67 (marker of proliferation Ki-67) with only 23 nodes, and
the largest one occurs in the network of DNAH11 (dynein, axonemal,
heavy chain 11) with 538 nodes. (PDF 177 kb)
Additional file 6: Figure S5. Distribution of the number of components
in haplotype networks of 42 genes with an excess of squares in their largest
component. The number of components ranges from one for gene POTED
(POTE ankyrin domain family, member D) to 1,111 for the highly fragmented
network of HLA-B. (PDF 63 kb)
Additional file 7: Figure S6. Two examples for the distribution of the
number of neighbors in the giant component of networks with an
excess of squares. Most haplotype networks have a skewed distribution
of the number of neighbors, of which the distribution in a) for PKD1L1
(polycystic kidney disease 1 like 1) is representative. A minority of
haplotype networks have a more symmetric distribution of this number
of neighbors, as exemplified by b) for the network of PRAMEF2 (PRAME
family member 2). (PDF 135 kb)
Additional file 8: Figure S7. Assortativity coefficient of haplotype
networks of genes with an excess of squares. A graph is (dis)assortative if
nodes with many neighbors tend to connect with other nodes that have
many (few) neighbors. This property can be quantified through an assortativity
coefficient, which is the Pearson correlation coefficient of degrees between
every pair of neighboring nodes [83]. The higher this assortativity coefficient,
the higher the tendency of a node to connect to other nodes with similar
number of neighbors. The graph shows the assortativity coefficient (vertical
axis) for the largest component of the haplotype network of each gene with
a significant excess of squares (horizontal axis). (PDF 259 kb)
Additional file 9: Figure S8. Recombination cannot produce the
observed number of squares. For each of 41 genes with a significant excess
of squares (horizontal axis), the vertical axis shows the number of squares in
the largest components of the gene’s haplotype network (black circles),
and the mean number of squares for corresponding networks created
through 1,000 population simulations with recombination (blue circles,
see Methods). The shaded area shows the minimum and maximum
number of squares in 1,000 randomized networks for each gene. From
the 42 genes with an excess of cycles, one gene (POTED, i.e., POTE
ANKYRIN DOMAIN FAMILY, MEMBER D) was excluded from the analysis
because it did not have any synonymous mutations, and so we could
not estimate its recombination rate. (PDF 635 kb)
Additional file 10: Table S1. Genes that showed a signal of positive
selection in the XP-CLR (cross-population composite likelihood ratio) test
[55]. Column one shows gene names and column two show the
populationpairs in which the gene was identified as significant. Numbers
in front of population pairs show the p-value of the most significant test
statistic window overlapping the gene. CEU: Utah Residents with
Northern and Western European ancestry; CHB: Han Chinese in Beijing,
China;YRI: Yoruba in Ibadan Nigeria. (DOC 29 kb)
Additional file 11: Table S2. Genes under positive selection as
detected from Selectome database [54]. The Selectome database
computes dN / dS ratio on branches of the phylogenetic tree of
vertebrates and, after correcting for multiple testing, identifies genes that
have a dN / dS ratio exceeding one on any specific tree branch. The table
shows genes among the 42 genes with excess of squares in their
network’s giant component that were detected by Selectome to be
under positive selection. The second column shows that branch on
which the gene was detected to be under positive selection. (DOC 32 kb)
Additional file 12: Table S3. Hypergeometric test on genes under
positive selection according to the XP-CLR test. From a total of six
possible tests between pairs of genes in the three populations (YRI,
CEU and CHB), only four tests showed evidence that any of the 42
genes with an excess of cycles were under positive selection. Table
columns, from left to right, show the corresponding population pairs, the
total number of genes in the analysis, the number of genes under positive
selection according to the test, the number of genes under positive
selection among the 42 genes with an excess of cycles, and the p-value of
the hypergeometric test. A p-value lower than 0.01 indicates that it is
unlikely to find as many genes in our dataset to be under positive selection
by chance alone. (DOC 29 kb)
Additional file 13: Figure S9. Fraction of edges without a single
synonymous change (horizontal axis) in the giant component and the whole
haplotype network of those 42 genes (left vertical axis) with significantly
more squares than expected by chance alone. The numbers on the right
vertical axis show the size of each haplotype network. (PDF 219 kb)
Additional file 14: Figure S10. The fraction of edges without a single
synonymous change inside and outside squares. For each of 42 genes
(horizontal axis) with significantly more squares than expected by chance
alone, vertical bars show the fraction of edges with no synonymous
change for edges that are part of a square (black bars) and that are not
part of a square (red bars). The fraction of edges without synonymous
mutations is not significantly different for edges inside squares compared
to edges outside squares for any gene (Mann-Whitney U test at p = 0.05
– corrected for multiple testing using [46]). (PDF 224 kb)
Additional file 15: Figure S11. Association between gene
heterozygosity and number of squares in the giant component of a
gene’s haplotype network. We calculated the heterozygosity of each
gene (n = 12,235) as the average fraction of individuals heterozygous in
that gene, where we took the average across all polymorphic sites in the
population. The correlation is very weak but significant (Pearson’s r = 0.066;
p = 3.42 × 10-13; n = 12,235). The blue line is based on linear regression.
(PDF 162 kb)
Additional file 16 : Figure S12. Correlation between the size of the
giant component and the number of cycles in the giant component of
haplotype networks (based on 12235 genes). Lines show results of linear
regression analysis. Red specifies genes with a significant excess of cycles
in their giant component (42 genes). The size of the giant component
and the number of cycles are significantly correlated both across all
genes and across genes with an excess of cycles (Pearson’s product-
moment correlation, p-value = 2.2 × 10-16 and p-value = 1.04 × 10-13 for
all genes and for genes with an excess of cycles). (PDF 600 kb)
Additional file 17: Figure S13. Distribution of the size of the giant
component in gene haplotype networks. The left panel shows this
distribution for all 12,235 genes with at least one amino acid changing
mutation (mean size of 35.7 haplotypes), and the right panel shows the
distribution for those 42 genes with excess of cycles (mean size of 179.0
haplotypes). The two distributions are significantly different from each
other (independent 2-group Mann- Whitney U Test, p-value = 2.2 × 10–16).
(PDF 478 kb)
Additional file 18: Figure S14. Elevated recombination rates or
increased effective population size cannot explain the observed number
of cycles. The vertical axes show the number of squares in the largest
components of a gene’s haplotype network (black circles), and the mean
number of squares for corresponding networks created through 1,000
population simulations with recombination (blue circles, see Methods).
The shaded areas show the minimum and maximum number of squares
in 1,000 randomized networks for each gene. a) Randomized networks
were constructed with twice the average recombination rate than in the
human genes, i.e. 1.90 cM/Mb. b) Randomized networks were constructed
based on ten times the estimated effective population size of humans, i.e.
100,000 individuals. All other calculations and procedures are the same as
described in the Methods section describing how randomized networks
with recombination were generated. From the 42 genes with an excess of
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cycles, one gene (POTED) was excluded from the analysis because it did
not have any synonymous mutations, and so we could not estimate its
recombination rate. (PDF 1358 kb)
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